Inspired by patients. Driven by science.
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.
Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.
UCB – The Facts
With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.
A few other reasons that make UCB an amazing place to work:
- Promising pipeline that includes several novel molecules;
- 2023 Key Financials: € 5.3 billion global revenue
Specialties: Neurology, Immunology
Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Home | UCB
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Life Science Leader Book and Periodical Publishing | Other 10 Oct 2022 | | ||
Future4Care Software Development | Other 31 Aug 2023 | | ||
epihunter healthtech, IT Services and IT Consulting | Other 15 May 2023 | | ||
Inlightened biotech, Information Services, deeptech, healthtech | Other 21 Oct 2022 | | ||
Talent Spaces edtech, Software Development | Other 30 Jun 2024 | | ||
Fortune Italia Book and Periodical Publishing | Other 1 Dec 2020 | | ||
Micro Focus IT Services and IT Consulting | Other 19 Jul 2022 | | ||
GrandParisDurable greentech, cleantech, Environmental Services | Other 31 Oct 2021 | | ||
Rofim healthtech, Hospitals and Health Care | Other 16 May 2022 29 Mar 2024 | | | |
BioWin deeptech, healthtech, Biotechnology Research | Other 23 Dec 2022 31 Jul 2024 | | |